Table 4 Association between ST14 expression and pathological features in ovarian cancer
From: ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
Features | Cases | High expression cases | High expression rate% | P-value |
|---|---|---|---|---|
FIGO stage | Â | Â | Â | 0.001*** |
I-II | 35 | 19 | 54.3 | |
III-IV | 56 | 48 | 85.7 | |
Differentiation | Â | Â | Â | 0.036* |
Well-moderate | 44 | 28 | 63.6 | |
Poorly | 47 | 39 | 83.0 | |
LNmetastasis | Â | Â | Â | 0.394 |
No | 40 | 28 | 70.0 | |
Yes | 28 | 23 | 82.1 | |
no lymphadenectomy | 23 | 16 | 69.6 | |
Pathologic type | Â | Â | Â | >0.05 |
Serous | 38 | 28 | 73.7 | |
Mucinous | 11 | 7 | 63.6 | |
Endometrioid | 18 | 12 | 66.7 | |
Clear cell carcinoma | 8 | 6 | 75.0 | |
Poorly differentiated adenocarcinoma | 16 | 14 | 87.5 |